Evidence map›Paper›PMID 42296404›Full record

ArticleChemistry & biodiversity2026

Deciphering Antidiabetic, Anti-Inflammatory, and Anti-Cholinergic Bioactivities of Withania somnifera (L) Dunal Root Extract: An In Vitro and In Silico Investigation.

Lufuno Mulelu, Jacqueline N Manjia, Kolawole A Olofinsan, Londiwe Xulu, Motlalepula G Matsabisa

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lufuno MuleluAfrican Medicines Innovations and Technologies Development, Department of Pharmacology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Jacqueline N ManjiaAfrican Medicines Innovations and Technologies Development, Department of Pharmacology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.ORCID https://orcid.org/0009-0002-8897-1866
Kolawole A OlofinsanAfrican Medicines Innovations and Technologies Development, Department of Pharmacology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Londiwe XuluAfrican Medicines Innovations and Technologies Development, Department of Pharmacology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Motlalepula G MatsabisaAfrican Medicines Innovations and Technologies Development, Department of Pharmacology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Funding

African Medicine Innovations and Technologies DevelopmentIK-based Technology Innovations at the Department of Science Technology and InnovationTechnology Innovation Agency
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a disease associated with loss of brain cholinergic functions and a common cause of dementia. Diabetes and inflammation have been linked to some pathways contributing to AD pathogenesis. In this study, the effects of Withania somnifera (W. somnifera) root ethanol extract (WSEE) on lipoxygenase, butyrylcholinesterase (BChE), protein denaturation, and carbohydrate digestive enzymes were determined using in vitro and in silico experimental models. WSEE cytotoxicity on neuroblastoma cell lines (SH-SY5Y) and the molecular docking simulation of its compounds were also investigated. WSEE analysis showed the presence of terpenoids, flavonoids, alkaloids, and tannins. The extract showed significant (p < 0.05) inhibition of protein denaturation (IC

Indexed as

Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalCholinesterase InhibitorsHypoglycemic AgentsPlant ExtractsWithaniaalpha-GlucosidasesButyrylcholinesteraseCell Line, TumorCell SurvivalDose-Response Relationship, DrugHumansLipoxygenaseMolecular Docking SimulationMolecular StructurePlant Rootsalpha-GlucosidasesAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalButyrylcholinesteraseCholinesterase InhibitorsHypoglycemic AgentsLipoxygenasePlant Extractsantidiabeticanti‐inflammatoryin siliconeuroblastoma cellsprotein denaturationWithania somnifera

Identifiers

PMID42296404
PMCPMC13268574

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.